APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Phosphoribosyltransferase

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nicotinamide Phosphoribosyltransferase Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchNicotinamide Phosphoribosyltransferase Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Phosphoribosyltransferase Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Nicotinamide Phosphoribosyltransferase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Phosphoribosyltransferase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Phosphoribosyltransferase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Nicotinamide Phosphoribosyltransferase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Phosphoribosyltransferase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nicotinamide Phosphoribosyltransferase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nicotinamide Phosphoribosyltransferase market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicotinamide Phosphoribosyltransferase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicotinamide Phosphoribosyltransferase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nicotinamide Phosphoribosyltransferase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nicotinamide Phosphoribosyltransferase Market by Company

OncoTartis, Inc.

Karyopharm Therapeutics, Inc.

Genentech, Inc.

FORMA Therapeutics, Inc.

Calico LLC

Aurigene Discovery Technologies Limited

Angelini Group

Nicotinamide Phosphoribosyltransferase Segment by Type

Lipids

Small Molecule Compounds

Hormone

Others

Nicotinamide Phosphoribosyltransferase Segment by Application

Breast Cancer

Parkinson's Disease

Acute Lung Injury

Others

Nicotinamide Phosphoribosyltransferase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nicotinamide Phosphoribosyltransferase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Lipids Table 2. Major Company of Small Molecule Compounds Table 3. Major Company of Hormone Table 4. Major Company of Others Table 5. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 7. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type (2021-2026) Table 8. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 9. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type (2021-2026) Table 10. Global Nicotinamide Phosphoribosyltransferase Price by Type (2021-2026) & (US$/Ton) Table 11. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 12. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type (2027-2032) Table 13. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (US$ Million) Table 14. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type (2027-2032) Table 15. Global Nicotinamide Phosphoribosyltransferase Price by Type (2027-2032) & (US$/Ton) Table 16. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 17. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 19. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 21. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 23. Latin America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 25. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (US$ Million) Table 26. Nicotinamide Phosphoribosyltransferase Industry Trends Table 27. Nicotinamide Phosphoribosyltransferase Industry Drivers Table 28. Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges Table 29. Nicotinamide Phosphoribosyltransferase Industry Restraints Table 30. Global Nicotinamide Phosphoribosyltransferase Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Company (2021-2026) Table 32. Global Nicotinamide Phosphoribosyltransferase Sales by Company (2021-2026) & (W Tons) Table 33. Global Nicotinamide Phosphoribosyltransferase Sales Share by Company (2021-2026) Table 34. Global Nicotinamide Phosphoribosyltransferase Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Nicotinamide Phosphoribosyltransferase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Nicotinamide Phosphoribosyltransferase Major Company Production Sites and Headquarters Table 37. Global Nicotinamide Phosphoribosyltransferase Company, Product Type & Application Table 38. Global Nicotinamide Phosphoribosyltransferase Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Nicotinamide Phosphoribosyltransferase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Nicotinamide Phosphoribosyltransferase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (W Tons) Table 43. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Region (2021-2026) Table 44. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (US$ Million) Table 45. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Region (2021-2026) Table 46. Global Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032) & (W Tons) Table 48. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Region (2027-2032) Table 49. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032) & (US$ Million) Table 50. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Region (2027-2032) Table 51. Global Nicotinamide Phosphoribosyltransferase Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 54. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application (2021-2026) Table 55. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 56. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application (2021-2026) Table 57. Global Nicotinamide Phosphoribosyltransferase Price by Application (2021-2026) & (US$/Ton) Table 58. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 59. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application (2027-2032) Table 60. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (US$ Million) Table 61. Global Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application (2027-2032) Table 62. Global Nicotinamide Phosphoribosyltransferase Price by Application (2027-2032) & (US$/Ton) Table 63. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 64. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 66. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 68. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 70. Latin America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 72. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (US$ Million) Table 73. OncoTartis, Inc. Company Information Table 74. OncoTartis, Inc. Business Overview Table 75. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 77. OncoTartis, Inc. Recent Development Table 78. Karyopharm Therapeutics, Inc. Company Information Table 79. Karyopharm Therapeutics, Inc. Business Overview Table 80. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 82. Karyopharm Therapeutics, Inc. Recent Development Table 83. Genentech, Inc. Company Information Table 84. Genentech, Inc. Business Overview Table 85. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 87. Genentech, Inc. Recent Development Table 88. FORMA Therapeutics, Inc. Company Information Table 89. FORMA Therapeutics, Inc. Business Overview Table 90. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 92. FORMA Therapeutics, Inc. Recent Development Table 93. Calico LLC Company Information Table 94. Calico LLC Business Overview Table 95. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio Table 97. Calico LLC Recent Development Table 98. Aurigene Discovery Technologies Limited Company Information Table 99. Aurigene Discovery Technologies Limited Business Overview Table 100. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio Table 102. Aurigene Discovery Technologies Limited Recent Development Table 103. Angelini Group Company Information Table 104. Angelini Group Business Overview Table 105. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio Table 107. Angelini Group Recent Development Table 108. North America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 109. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 110. North America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 111. North America Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032) & (W Tons) Table 112. North America Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Country (2027-2032) Table 113. North America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Nicotinamide Phosphoribosyltransferase Market Share by Country (2021-2026) Table 116. North America Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Nicotinamide Phosphoribosyltransferase Market Share Forecast by Country (2027-2032) Table 118. Europe Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 119. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 120. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 121. Europe Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032) & (W Tons) Table 122. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Nicotinamide Phosphoribosyltransferase Market Share by Country (2021-2026) Table 126. Europe Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Nicotinamide Phosphoribosyltransferase Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 130. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032) & (W Tons) Table 132. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Share by Country (2021-2026) Table 136. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Share Forecast by Country (2027-2032) Table 138. Latin America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 139. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 140. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 141. Latin America Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032) & (W Tons) Table 142. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Nicotinamide Phosphoribosyltransferase Market Share by Country (2021-2026) Table 146. Latin America Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Nicotinamide Phosphoribosyltransferase Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 150. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032) & (W Tons) Table 152. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Share by Country (2021-2026) Table 156. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Nicotinamide Phosphoribosyltransferase Distributors List Table 161. Nicotinamide Phosphoribosyltransferase Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Nicotinamide Phosphoribosyltransferase Image Figure 2. Global Nicotinamide Phosphoribosyltransferase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Phosphoribosyltransferase Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Phosphoribosyltransferase Sales (2021-2032) & (W Tons) Figure 5. Lipids Image Figure 6. Global Lipids Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Small Molecule Compounds Image Figure 8. Global Small Molecule Compounds Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Hormone Image Figure 10. Global Hormone Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 13. Global Nicotinamide Phosphoribosyltransferase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Nicotinamide Phosphoribosyltransferase Market Share by Type 2025 VS 2032 Figure 15. North America Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type in 2025 Figure 16. North America Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type in 2025 Figure 17. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type in 2025 Figure 18. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type in 2025 Figure 21. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Nicotinamide Phosphoribosyltransferase Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Parkinson's Disease Image Figure 30. Global Parkinson's Disease Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Acute Lung Injury Image Figure 32. Global Acute Lung Injury Sales YoY Growth (2021-2032) & (W Tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 35. Global Nicotinamide Phosphoribosyltransferase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nicotinamide Phosphoribosyltransferase Market Share by Application 2025 VS 2032 Figure 37. North America Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application in 2025 Figure 38. North America Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application in 2025 Figure 39. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application in 2025 Figure 40. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application in 2025 Figure 43. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Market Share in Value by Application in 2025 Figure 47. North America Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. North America Nicotinamide Phosphoribosyltransferase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Nicotinamide Phosphoribosyltransferase Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Europe Nicotinamide Phosphoribosyltransferase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Nicotinamide Phosphoribosyltransferase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Latin America Nicotinamide Phosphoribosyltransferase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Nicotinamide Phosphoribosyltransferase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 64. Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nicotinamide Phosphoribosyltransferase Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Nicotinamide Phosphoribosyltransferase Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Lipids
  • Small Molecule Compounds
  • Hormone
  • Others
Applications
  • Breast Cancer
  • Parkinson's Disease
  • Acute Lung Injury
  • Others
Companies covered
  • OncoTartis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Genentech, Inc.
  • FORMA Therapeutics, Inc.
  • Calico LLC
  • Aurigene Discovery Technologies Limited
  • Angelini Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nicotinamide Phosphoribosyltransferase Market by Type
  6. 1.3.1 Lipids
  7. 1.3.2 Small Molecule Compounds
  8. 1.3.3 Hormone
  9. 1.3.4 Others
  10. 1.4 Global Nicotinamide Phosphoribosyltransferase Market Size by Type
  11. 1.4.1 Global Nicotinamide Phosphoribosyltransferase Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Nicotinamide Phosphoribosyltransferase Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Nicotinamide Phosphoribosyltransferase Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Nicotinamide Phosphoribosyltransferase Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Nicotinamide Phosphoribosyltransferase Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Nicotinamide Phosphoribosyltransferase Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nicotinamide Phosphoribosyltransferase Industry Trends
  2. 2.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
  3. 2.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nicotinamide Phosphoribosyltransferase Revenue (2021-2026)
  2. 3.2 Global Top Players by Nicotinamide Phosphoribosyltransferase Sales (2021-2026)
  3. 3.3 Global Top Players by Nicotinamide Phosphoribosyltransferase Price (2021-2026)
  4. 3.4 Global Nicotinamide Phosphoribosyltransferase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinamide Phosphoribosyltransferase Major Company Production Sites & Headquarters
  6. 3.6 Global Nicotinamide Phosphoribosyltransferase Company, Product Type & Application
  7. 3.7 Global Nicotinamide Phosphoribosyltransferase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotinamide Phosphoribosyltransferase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotinamide Phosphoribosyltransferase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicotinamide Phosphoribosyltransferase Tier 1, Tier 2, and Tier 3
4 Nicotinamide Phosphoribosyltransferase Regional Status and Outlook
  1. 4.1 Global Nicotinamide Phosphoribosyltransferase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nicotinamide Phosphoribosyltransferase Historic Market Size by Region
  3. 4.2.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nicotinamide Phosphoribosyltransferase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nicotinamide Phosphoribosyltransferase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nicotinamide Phosphoribosyltransferase Forecasted Market Size by Region
  7. 4.3.1 Global Nicotinamide Phosphoribosyltransferase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nicotinamide Phosphoribosyltransferase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nicotinamide Phosphoribosyltransferase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicotinamide Phosphoribosyltransferase by Application
  1. 5.1 Nicotinamide Phosphoribosyltransferase Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Acute Lung Injury
  5. 5.1.4 Others
  6. 5.2 Global Nicotinamide Phosphoribosyltransferase Market Size by Application
  7. 5.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nicotinamide Phosphoribosyltransferase Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nicotinamide Phosphoribosyltransferase Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nicotinamide Phosphoribosyltransferase Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nicotinamide Phosphoribosyltransferase Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nicotinamide Phosphoribosyltransferase Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 OncoTartis, Inc.
  2. 6.1.1 OncoTartis, Inc. Company Information
  3. 6.1.2 OncoTartis, Inc. Business Overview
  4. 6.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  6. 6.1.5 OncoTartis, Inc. Recent Developments
  7. 6.2 Karyopharm Therapeutics, Inc.
  8. 6.2.1 Karyopharm Therapeutics, Inc. Company Information
  9. 6.2.2 Karyopharm Therapeutics, Inc. Business Overview
  10. 6.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  12. 6.2.5 Karyopharm Therapeutics, Inc. Recent Developments
  13. 6.3 Genentech, Inc.
  14. 6.3.1 Genentech, Inc. Company Information
  15. 6.3.2 Genentech, Inc. Business Overview
  16. 6.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  18. 6.3.5 Genentech, Inc. Recent Developments
  19. 6.4 FORMA Therapeutics, Inc.
  20. 6.4.1 FORMA Therapeutics, Inc. Company Information
  21. 6.4.2 FORMA Therapeutics, Inc. Business Overview
  22. 6.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  24. 6.4.5 FORMA Therapeutics, Inc. Recent Developments
  25. 6.5 Calico LLC
  26. 6.5.1 Calico LLC Company Information
  27. 6.5.2 Calico LLC Business Overview
  28. 6.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
  30. 6.5.5 Calico LLC Recent Developments
  31. 6.6 Aurigene Discovery Technologies Limited
  32. 6.6.1 Aurigene Discovery Technologies Limited Company Information
  33. 6.6.2 Aurigene Discovery Technologies Limited Business Overview
  34. 6.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
  36. 6.6.5 Aurigene Discovery Technologies Limited Recent Developments
  37. 6.7 Angelini Group
  38. 6.7.1 Angelini Group Company Information
  39. 6.7.2 Angelini Group Business Overview
  40. 6.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
  42. 6.7.5 Angelini Group Recent Developments
7 North America by Country
  1. 7.1 North America Nicotinamide Phosphoribosyltransferase Sales by Country
  2. 7.1.1 North America Nicotinamide Phosphoribosyltransferase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  4. 7.1.3 North America Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nicotinamide Phosphoribosyltransferase Market Size by Country
  6. 7.2.1 North America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026)
  8. 7.2.3 North America Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nicotinamide Phosphoribosyltransferase Sales by Country
  2. 8.1.1 Europe Nicotinamide Phosphoribosyltransferase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  4. 8.1.3 Europe Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country
  6. 8.2.1 Europe Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Country
  2. 9.1.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country
  6. 9.2.1 Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nicotinamide Phosphoribosyltransferase Sales by Country
  2. 10.1.1 South America Nicotinamide Phosphoribosyltransferase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  4. 10.1.3 South America Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nicotinamide Phosphoribosyltransferase Market Size by Country
  6. 10.2.1 South America Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026)
  8. 10.2.3 South America Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country
  2. 11.1.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country
  6. 11.2.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
  2. 12.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nicotinamide Phosphoribosyltransferase Production Mode & Process
  7. 12.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nicotinamide Phosphoribosyltransferase Distributors
  10. 12.2.3 Nicotinamide Phosphoribosyltransferase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst